Khurana And Khurana (K&K) Advises Medikabazaar On Its Series C Funding
Khurana and Khurana acted as the IP Counsel for Medikabazaar on its recent funding round where the Company, a leading B2B health-tech entity, raised $75 million in its Series C funding round that was led by CREAEGIS along with CDC Group. K&K advised Medikabazaar on IP Law issues during its highest fundraising in the B2B healthcare … Continue reading Khurana And Khurana (K&K) Advises Medikabazaar On Its Series C Funding
Read more »